First trimester inhibin-A concentrations and later development of preeclampsia [1]

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 1, 2004, Pages 117-

  Roes, E M ^b   Gaytant, M A ^b   Thomas, C M G ^b   Raijmakers, M T M ^b   Zusterzeel, P L M ^b   Peters, W H M ^b   Steegers, E A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN A;

AMENORRHEA; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HELLP SYNDROME; HUMAN; LETTER; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SENSITIVITY AND SPECIFICITY; VEIN PUNCTURE;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 1642430646     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2004.00140.x     Document Type: Letter

References (6)

1. D'Anna R, Baviera G, Corrado F, Leonardi I, Buemi M, Jasonni VM. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81: 540-3.
2. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 1101-3.
3. Wald NJ & Morris JK. Multiple marker second trimester serum screening for pre-eclampsia. J Med Screen 2001; 8: 65-8.
4. Groome N & O'Brien M. Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunol Methods 1993; 165: 167-76.
5. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12: 301-8.
6. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80: 83-6.